Canada Diabetes Care Devices Market

Canada Diabetes Care Devices Market by Type of Management Devices (Insulin Pumps, Insulin Syringes, Insulin Disposable Pens, Insulin Cartridges in Reusable Pens, and Insulin Jet Injectors), Monitoring Devices (Self-monitoring Blood Glucose and Continuous Glucose Monitoring), and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-2928
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 202
  • Format:
  • Pub. Date: Upcoming
  • Share:

The Canada diabetes care devices market size is expected to reach USD 2.1 billion by 2028 and is anticipated to expand at a high CAGR during the forecast period, 2021- 2028. The growth of the market is attributed to increasing prevalence of diabetes in low- and middle-income countries.


Canada Diabetes Care Devices Market summary

A person’s body with diabetes commonly produce almost no insulin in pancreas. Obesity and inactive lifestyle are the major cause of diabetes. According to the data published by the Conference Board of Canada, around 2 million people in Canada are found with diabetes condition, which means one in 16 people have diabetes. As per the study conducted by Diabetes Canada, 12.1% or around 5 million of Canada-based population can be diagnosed with diabetes. Type-1 and type-2 are the two types of diabetes.

Market Trends Drivers, Restraints and Opportunities

  • The rise in obesity population and prevalence of unhealthy lifestyle are some of the major factors that can propel the market growth.
  • Increasing government funding for diabetes management and presence of reimbursement policies can spur the growth of the market.
  • Technological advancements and increasing requirement for faster and safer diagnosis and treatment of diabetes are the key factors that can support the industry growth during the forecast period.

Scope of the Report

The report on the Canada Diabetes Care Devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report

Attributes

Details

Report Title

Canada Diabetes Care Devices Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

 
Segmentation

Type of Management Devices (Insulin Pumps, Insulin Syringes, Insulin Disposable Pens, Insulin Cartridges in Reusable Pens, and Insulin Jet Injectors) and Monitoring Devices (Self-monitoring Blood Glucose and Continuous Glucose Monitoring)

Country

Canada

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Dexcom; Medtronic; Novo Nordisk A/S; F. Hoffmann-La Roche AG; Abbott Diabetes Care

Canada Diabetes Care Devices Market Segment Insights

Diabetes management mobile applications segment is projected to exhibit high CAGR

On the basis of monitoring devices, the market is segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. The diabetes management mobile applications segment is accepted to grow at high rate during forecast period. Rising use of mobile phones to manage the diabetes is driving the market growth. On the other hand, the blood glucose monitoring systems segment is estimated to account a major market share in the coming years. Increasing demand for glucose monitoring devices to self-monitor the diabetes is propelling the segment growth.

Insulin syringes segment to account a major market share

Based on type of management devices, the Canada diabetes care devices market is divided into insulin pumps, insulin syringes, insulin disposable pens, insulin cartridges in reusable pens, insulin jet injectors. The insulin syringes segment is anticipated to account for a major market share during the forecast period. The cost-effectiveness and easy availability of insulin syringes are some of the factors driving the growth of the market segment.

The insulin jet injectors segment is anticipated to exhibit a high CAGR during the forecast period. Insulin jet injectors are claimed to be relatively-free, which is spurring the demand for them among diabetic patients.


Canada Diabetes Care Devices Market types

Segments

Segments Covered in the Report
The Canada diabetes care devices market has been segmented on the basis of:
Type of Management Devices

  • Insulin Jet Injectors
  • Insulin Pumps
  • Insulin Syringes
  • Insulin Disposable Pens
  • Insulin Cartridges in Reusable Pens

Monitoring Devices

  • Self-monitoring Blood Glucose
  • Continuous Glucose Monitoring

Country

  • Canada

Key Players

  • Dexcom
  • Medtronic
  • Novo Nordisk A/S
  • F. Hoffmann-La Roche AG
  • Abbott Diabetes Care

 

Competitive Landscape

Key players competing in the Canada Diabetes Care Devices Market are Dexcom; Medtronic; Novo Nordisk A/S; F. Hoffmann-La Roche AG; Abbott Diabetes Care. Companies are focusing on partnering with local manufacturers and collaborating with other industry players to expand their market share. Constant innovations are made by the manufacturers so that they can still remain into the market.

In April 2021, Medtronic announced the launch of the Medtronic Extended Infusion set in selected Europe-based countries. The set can be worn for up to seven days. It claims that it maintains the insulin flow and stability. However, the set is still in investigational use in the US.

In December 2020, Abbott introduced FreeStyle Libre 2, a sensor-based glucose monitoring technology, which has been already approved by Health Canada for individuals above 4 years. The technology allows the patients to get real-time alerts, which eliminates the use of painful needles.

Canada Diabetes Care Devices Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Diabetes Care Devices Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Diabetes Care Devices Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Diabetes Care Devices Market - Supply Chain
  4.5. Global Diabetes Care Devices Market Forecast
     4.5.1. Diabetes Care Devices Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Diabetes Care Devices Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Diabetes Care Devices Market Absolute $ Opportunity
5. Global Diabetes Care Devices Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Diabetes Care Devices Market Size and Volume Forecast by Types
     5.3.1. Insulin Jet Injectors
     5.3.2. Insulin Pumps
     5.3.3. Insulin Syringes
     5.3.4. Insulin Disposable Pens
     5.3.5. Insulin Cartridges in Reusable Pens
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Diabetes Care Devices Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Diabetes Care Devices Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Diabetes Care Devices Demand Share Forecast, 2019-2026
7. North America Diabetes Care Devices Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Diabetes Care Devices Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Diabetes Care Devices Market Size and Volume Forecast by Types
     7.4.1. Insulin Jet Injectors
     7.4.2. Insulin Pumps
     7.4.3. Insulin Syringes
     7.4.4. Insulin Disposable Pens
     7.4.5. Insulin Cartridges in Reusable Pens
  7.5. Basis Point Share (BPS) Analysis by Types
  7.6. Y-o-Y Growth Projections by Types
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Diabetes Care Devices Demand Share Forecast, 2019-2026
8. Latin America Diabetes Care Devices Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Diabetes Care Devices Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Diabetes Care Devices Market Size and Volume Forecast by Types
     8.4.1. Insulin Jet Injectors
     8.4.2. Insulin Pumps
     8.4.3. Insulin Syringes
     8.4.4. Insulin Disposable Pens
     8.4.5. Insulin Cartridges in Reusable Pens
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Diabetes Care Devices Demand Share Forecast, 2019-2026
9. Europe Diabetes Care Devices Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Diabetes Care Devices Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Diabetes Care Devices Market Size and Volume Forecast by Types
     9.4.1. Insulin Jet Injectors
     9.4.2. Insulin Pumps
     9.4.3. Insulin Syringes
     9.4.4. Insulin Disposable Pens
     9.4.5. Insulin Cartridges in Reusable Pens
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Diabetes Care Devices Demand Share Forecast, 2019-2026
10. Asia Pacific Diabetes Care Devices Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Diabetes Care Devices Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Diabetes Care Devices Market Size and Volume Forecast by Types
     10.4.1. Insulin Jet Injectors
     10.4.2. Insulin Pumps
     10.4.3. Insulin Syringes
     10.4.4. Insulin Disposable Pens
     10.4.5. Insulin Cartridges in Reusable Pens
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Diabetes Care Devices Demand Share Forecast, 2019-2026
11. Middle East & Africa Diabetes Care Devices Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Diabetes Care Devices Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Diabetes Care Devices Market Size and Volume Forecast by Types
     11.4.1. Insulin Jet Injectors
     11.4.2. Insulin Pumps
     11.4.3. Insulin Syringes
     11.4.4. Insulin Disposable Pens
     11.4.5. Insulin Cartridges in Reusable Pens
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Diabetes Care Devices Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Diabetes Care Devices Market: Market Share Analysis
  12.2. Diabetes Care Devices Distributors and Customers
  12.3. Diabetes Care Devices Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Dexcom
     12.4.2. Medtronic
     12.4.3. Novo Nordisk A/S
     12.4.4. F. Hoffmann-La Roche AG
     12.4.5. Abbott Diabetes Care

Segments Covered in the Report
The Canada diabetes care devices market has been segmented on the basis of:
Type of Management Devices

  • Insulin Jet Injectors
  • Insulin Pumps
  • Insulin Syringes
  • Insulin Disposable Pens
  • Insulin Cartridges in Reusable Pens

Monitoring Devices

  • Self-monitoring Blood Glucose
  • Continuous Glucose Monitoring

Country

  • Canada

Key Players

  • Dexcom
  • Medtronic
  • Novo Nordisk A/S
  • F. Hoffmann-La Roche AG
  • Abbott Diabetes Care

 

Key players competing in the Canada Diabetes Care Devices Market are Dexcom; Medtronic; Novo Nordisk A/S; F. Hoffmann-La Roche AG; Abbott Diabetes Care. Companies are focusing on partnering with local manufacturers and collaborating with other industry players to expand their market share. Constant innovations are made by the manufacturers so that they can still remain into the market.

In April 2021, Medtronic announced the launch of the Medtronic Extended Infusion set in selected Europe-based countries. The set can be worn for up to seven days. It claims that it maintains the insulin flow and stability. However, the set is still in investigational use in the US.

In December 2020, Abbott introduced FreeStyle Libre 2, a sensor-based glucose monitoring technology, which has been already approved by Health Canada for individuals above 4 years. The technology allows the patients to get real-time alerts, which eliminates the use of painful needles.

Canada Diabetes Care Devices Market keyplayers

Buy Report